Feedback / Questions
DA 3111 (trastuzumab biosimilar) - Meiji Seika, Dong-A
Meiji Seika Pharma: FY 2014 Results
(Meiji Seika)
-
May 31, 2014 -
Anticipated completion of P1 trial for cancer in FY 2015
Anticipated trial completion date
•
Biosimilar
http://www.meiji.com/english/investor/library/settlement/2013/pdf/settlement_2013_r04_en_presentation.pdf
May 31, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.